Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Tsarkake>98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory
Ruifu Chemical Supply Lenvatinib Mesylate Matsakaici Tare da Babban Tsafta
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1- (2-Chloro-4-Hydroxyphenyl) -3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dion CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Sunan Sinadari | Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate |
Makamantu | Lenvatinib rashin tsarki 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D |
Lambar CAS | 205448-66-4 |
Lambar CAT | Saukewa: RF-PI1970 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C12H10ClNO3 |
Nauyin Kwayoyin Halitta | 251.67 |
Wurin Tafasa | 377.4 ± 37.0 ℃ |
Yawan yawa | 1.320± 0.06 g/cm3 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Kashe-Fara zuwa Fada mai ƙarfi na rawaya |
1 H NMR Spectrum | Daidaita Da Tsarin |
Tsarkake / Hanyar Bincike | 98.0% (HPLC) |
Asara akan bushewa | <1.00% |
Jimlar ƙazanta | <2.00% |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaici/ Rashin Tsabta na Lenvatinib Mesylate (CAS: 857890-39-2) |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) matsakaici ne na Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib magani ne na ciwon daji na thyroid wanda Eisai Corporation na Japan ya haɓaka (Lambar: E7080), mallakar mai hanawa na tyrosine kinase mai karɓa na baka (RTK) kuma yana iya hana aikin kinase na jijiyoyi masu haɓaka haɓakar haɓakar jijiyoyi R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Lenvatinib kuma zai iya hana shigar da sauran RTKs a cikin angiogenesis na pathological, ci gaban tumo, da ci gaban ciwon daji sai dai don ayyukan salula na yau da kullum ciki har da masu karɓar fibroblast girma factor (FGF) FGFR1, 2, 3, da 4;Mai karɓar haɓakar haɓakar platelet (PDGFR [alpha]), KIT, da RET.[Alamomi]: Lenvatinib ya dace da maganin marasa lafiya na ciwon daji na thyroid na sake dawowa gida ko nau'in metastasis, nau'in ci gaba da nau'in rediyoaktif-refractory daban-daban.